{"Title": ["Implied Volatility Surging for Anthera Pharmaceuticals (ANTH) Stock Options", "What's in Store for Cardinal Health (CAH) in Q2 Earnings?", "Can Molecular Diagnostics Arm Up Hologic (HOLX) Q1 Earnings?", "Will Higher System Sales Drive Cerner's (CERN) Q4 Earnings?", "Health Care Sector Update for 01/22/2018: JUNO,CELG,ANTH,INO,TEVA", "Health Care Sector Update for 01/22/2018: ANTH,INO,TEVA", "Ultragenyx Announces Interim Data from Early Stage Study", "Health Care Sector Update for 11/20/2017: SMMT,ACST,ACST.V,ANTH", "Implied Volatility Surging for Anthera Pharmaceuticals (ANTH) Stock Options", "Health Care Sector Update for 10/24/2017: ANTH,PTIE,IMDZ", "Anthera's Blisibimod Positive in Phase II Extension Study", "Axovant Sciences (AXON) Shows Strength: Stock Jumps 9.2%", "ANTH's (ANTH) Blisibimod Completes Dosing in Phase III Study", "Should You Get Rid of Aimmune Therapeutics (AIMT) Now?", "BioTelemetry (BEAT) Shows Strength: Stock Moves 8.8% Higher", "Cellect Biotechnology (APOP) Jumps: Stock Moves 10.5% Higher", "Health Care Sector Update for 11/20/2017: ACOR,ACST,ACST.V,ANTH", "Cara Therapeutics (CARA) Shows Strength: Stock Up 5.2%", "Will Endo's Troubles Continue to Dent Performance in 2017?", "AstraZeneca's Lung Cancer Drug Tagrisso Approved in China", "Merrimack (MACK) Starts Enrollment in Solid Tumors Study", "OvaScience, Inc. (OVAS) Looks Good: Stock Up 9.6% Higher", "Shire (SHPG) Rare Disease Drug Gets Fast Track Designation", "Enzo Biochem, Inc. (ENZ) Shows Strength: Stock Up 5.2%", "Bill Ackman Apologizes for Valeant Investment Error", "Fortress Biotech (FBIO) Catches Eye: Stock Moves Up 8.3%", "Implied Volatility Surging for Anthera (ANTH) Stock Options", "Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase", "Inovio (INO) Q4 Loss Wider than Expected; Shares Decline", "Rexahn Pharmaceuticals (RNN) Jumps: Stock Moves Up 5.4%", "Shire's (SHPG) Cinryze Label Expanded for Pediatric Use", "Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA", "AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher", "Health Care Sector Update for 03/14/2017: ATRS,ETRM,ANTH", "VIVUS (VVUS) Beats on Q4 Earnings, Revenues Increase Y/Y", "New Strong Buy Stocks for March 8th", "Health Care Sector Update for 12/29/2016: SNY, NVS, GALE, ANTH, NVO", "Anthera (ANTH) Stock Falls on Poor Phase III Sollpura Data", "3 Stocks to Watch on Wednesday: Ford Motor Company (F), Galena Biopharma Inc (GALE) and Anthera Pharmaceuticals Inc (ANTH)", "Health Care Sector Update for 12/28/2016: SNY, ANTH, JNJ, PFE, ABT, MRK, AMGN", "Health Care Sector Update for 03/14/2017: AUPH,ETRM,ANTH", "Health Care Sector Update for 12/28/2016: SNY,NVS,GALE,ANTH", "Health Care Sector Update for 12/28/2016: CXRX,GALE,ANTH", "Wednesday Sector Laggards: Music & Electronics Stores, Biotechnology Stocks", "Are Options Traders Betting on a Big Move in Anthera Pharmaceuticals (ANTH) Stock?", "3 Stocks to Watch on Wednesday: Anthera Pharmaceuticals Inc (ANTH), Mastercard Inc (MA) and Western Digital Corp (WDC)", "Health Care Sector Update for 12/07/2016: CTSO,ANTH,RPRX", "Health Care Sector Update for 12/07/2016: CGIX,ANTH,RPRX", "Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold", "Health Care Sector Update for 11/10/2016: OMER,MNKD,ANTH", "Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 7.9%", "Health Care Sector Update for 08/17/2016: ANTH,CNC,INCR", "Midday Update: Stocks Find Excuse to Retreat From Record Highs on Hawkish Fed-Speak", "Close Update: Stocks Pressured by Hawkish Fed-Speak", "Health Care Sector Update for 06/29/2016: ANTH,TSRO,GALE", "Can the Rally in Anthera (ANTH) Shares Continue?", "Wednesday Sector Laggards: Precious Metals, Biotechnology Stocks", "Health Care Sector Update for 03/07/2016: MSLI, ANTH", "After-Hours Earnings Report for November 6, 2015 : ANTH, HNRG", "Tuesday Sector Laggards: Drugs, Biotechnology Stocks", "Spark Therapeutics (ONCE) Slumps: Falls 11.1% in Session", "New Strong Buy Stocks for October 6th", "New Strong Buy Stocks for September 30th", "Can The Uptrend Continue for Anthera (ANTH)?", "Analysts Anticipate IWV To Hit $133", "Health Care Sector Update for 03/07/2016: MSLI, ANTH", "Should You Sell Anthera Pharmaceuticals (ANTH) Before Earnings? - Tale of the Tape", "Mid-Afternoon Market Update: Micron Gains On Rumor Of Tsinghua Bid; Navient Shares Drop", "Health Care Sector Update for 07/09/2015: ANTH,IPCI,AQXP", "The Reason Behind Anthera Pharmaceuticals' Nasty Tumble", "Forget Biogen (BIIB), Buy These 3 Biotechnology Stocks Instead - Stocks in the News", "Why Anthera Pharmaceuticals, Inc. Shares Are Soaring Higher", "The Zacks Analyst Blog Highlights: Medivation, Gilead Sciences, Regeneron Pharmaceuticals and Anthera Pharmaceuticals", "Will Anthera Pharmaceuticals (ANTH) Continue to Surge Higher? - Tale of the Tape", "The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases", "Strength Seen in Anthera (ANTH): Stock Soars 25% - Tale of the Tape", "Health Care Sector Update for 02/11/2015: ANTH,HTBX,DCTH", "Can the Uptrend Continue for Anthera Pharmaceuticals (ANTH)? - Tale of the Tape", "Qiagen's Molecular Diagnostics, Global Market Show Strength - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Health Care Sector Update for 06/05/2015: ANTH,PTN,ORMP", "Will Anthera Pharmaceuticals (ANTH) Continue to Surge Higher? - Tale of the Tape", "The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases", "Strength Seen in Anthera (ANTH): Stock Soars 25% - Tale of the Tape", "Exelixis (EXEL) Soars: Stock Adds 23% in Session - Tale of the Tape", "Sector Update: Health Care Stocks Swept Up in Biotech Sell-Off as Fed Sees Values 'Stretched'", "Sector Update: Health Care", "Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape", "Genomic Health Upbeat on Strong International Performance - Analyst Blog", "Biogen Upped to Outperform - Analyst Blog", "Data Published on Alnylam's ATTR Candidates - Analyst Blog", "Voluntary Recall at Alexion - Analyst Blog", "MannKind to Raise $40M from Deerfield - Analyst Blog", "Pre-Market Most Active for Mar 12, 2012 : BAC, ING, ZOLL, YOKU, RIO, SIRI, QQQ, UN, OREX, ANTH, ABB, AAPL", "Zacks #5 Rank Additions for Thursday - Tale of the Tape", "Wall Street Experts: Deutsche Bank Loves These Stocks Boosted by Insider Buying", "BioLineRx Files for BL-7010 Study Initiation - Analyst Blog"], "Elapsed Time": ["FEB 26, 2018", "JAN 30, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 8, 2018", "NOV 20, 2017", "FEB 26, 2018", "OCT 24, 2017", "AUG 29, 2017", "APR 12, 2017", "APR 11, 2017", "APR 11, 2017", "APR 11, 2017", "APR 4, 2017", "NOV 20, 2017", "MAR 29, 2017", "MAR 28, 2017", "MAR 27, 2017", "MAR 24, 2017", "MAR 23, 2017", "MAR 23, 2017", "MAR 21, 2017", "MAR 30, 2017", "MAR 20, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 20, 2017", "MAR 14, 2017", "MAR 9, 2017", "MAR 8, 2017", "DEC 29, 2016", "DEC 28, 2016", "DEC 28, 2016", "DEC 28, 2016", "MAR 14, 2017", "DEC 28, 2016", "DEC 28, 2016", "DEC 28, 2016", "DEC 27, 2016", "DEC 7, 2016", "DEC 7, 2016", "DEC 7, 2016", "DEC 28, 2016", "NOV 10, 2016", "AUG 17, 2016", "AUG 17, 2016", "AUG 16, 2016", "AUG 16, 2016", "JUN 29, 2016", "JUN 3, 2016", "NOV 30, 2016", "MAR 7, 2016", "NOV 6, 2015", "OCT 20, 2015", "OCT 8, 2015", "OCT 6, 2015", "SEP 30, 2015", "SEP 23, 2015", "APR 13, 2016", "MAR 7, 2016", "JUL 24, 2015", "JUL 14, 2015", "JUL 9, 2015", "JUL 9, 2015", "JUL 6, 2015", "JUN 5, 2015", "SEP 21, 2015", "MAY 29, 2015", "APR 22, 2015", "FEB 11, 2015", "FEB 11, 2015", "JAN 7, 2015", "SEP 26, 2014", "SEP 25, 2014", "JUN 5, 2015", "MAY 29, 2015", "APR 22, 2015", "JUL 18, 2014", "JUL 15, 2014", "JUL 15, 2014", "JUL 15, 2014", "MAY 16, 2014", "SEP 25, 2014", "SEP 19, 2013", "AUG 29, 2013", "AUG 21, 2013", "AUG 19, 2013", "MAR 12, 2012", "FEB 23, 2012", "JAN 9, 2012", "SEP 25, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/implied-volatility-surging-for-anthera-pharmaceuticals-anth-stock-options-2018-02-26", "https://www.nasdaq.com/articles/whats-in-store-for-cardinal-health-cah-in-q2-earnings-2018-01-30", "https://www.nasdaq.com/articles/can-molecular-diagnostics-arm-up-hologic-holx-q1-earnings-2018-01-29", "https://www.nasdaq.com/articles/will-higher-system-sales-drive-cerners-cern-q4-earnings-2018-01-29", "https://www.nasdaq.com/articles/health-care-sector-update-01222018-junocelganthinoteva-2018-01-22", "https://www.nasdaq.com/articles/health-care-sector-update-01222018-anthinoteva-2018-01-22", "https://www.nasdaq.com/articles/ultragenyx-announces-interim-data-from-early-stage-study-2018-01-08", "https://www.nasdaq.com/articles/health-care-sector-update-11202017-smmtacstacstvanth-2017-11-20", "https://www.nasdaq.com/articles/implied-volatility-surging-for-anthera-pharmaceuticals-anth-stock-options-2018-02-26", "https://www.nasdaq.com/articles/health-care-sector-update-10242017-anthptieimdz-2017-10-24", "https://www.nasdaq.com/articles/antheras-blisibimod-positive-in-phase-ii-extension-study-2017-08-29", "https://www.nasdaq.com/articles/axovant-sciences-axon-shows-strength-stock-jumps-92-2017-04-12", "https://www.nasdaq.com/articles/anths-anth-blisibimod-completes-dosing-in-phase-iii-study-2017-04-11", "https://www.nasdaq.com/articles/should-you-get-rid-of-aimmune-therapeutics-aimt-now-2017-04-11", "https://www.nasdaq.com/articles/biotelemetry-beat-shows-strength%3A-stock-moves-8.8-higher-2017-04-11", "https://www.nasdaq.com/articles/cellect-biotechnology-apop-jumps%3A-stock-moves-10.5-higher-2017-04-04", "https://www.nasdaq.com/articles/health-care-sector-update-11202017-acoracstacstvanth-2017-11-20", "https://www.nasdaq.com/articles/cara-therapeutics-cara-shows-strength%3A-stock-up-5.2-2017-03-29", "https://www.nasdaq.com/articles/will-endos-troubles-continue-to-dent-performance-in-2017-2017-03-28", "https://www.nasdaq.com/articles/astrazenecas-lung-cancer-drug-tagrisso-approved-in-china-2017-03-27", "https://www.nasdaq.com/articles/merrimack-mack-starts-enrollment-in-solid-tumors-study-2017-03-24", "https://www.nasdaq.com/articles/ovascience-inc.-ovas-looks-good%3A-stock-up-9.6-higher-2017-03-23", "https://www.nasdaq.com/articles/shire-shpg-rare-disease-drug-gets-fast-track-designation-2017-03-23", "https://www.nasdaq.com/articles/enzo-biochem-inc.-enz-shows-strength%3A-stock-up-5.2-2017-03-21", "https://www.nasdaq.com/articles/bill-ackman-apologizes-for-valeant-investment-error-2017-03-30", "https://www.nasdaq.com/articles/fortress-biotech-fbio-catches-eye%3A-stock-moves-up-8.3-2017-03-20", "https://www.nasdaq.com/articles/implied-volatility-surging-for-anthera-anth-stock-options-2017-03-17", "https://www.nasdaq.com/articles/valeant-vrx-shares-up-on-valueacts-5.2-stake-increase-2017-03-17", "https://www.nasdaq.com/articles/inovio-ino-q4-loss-wider-than-expected-shares-decline-2017-03-16", "https://www.nasdaq.com/articles/rexahn-pharmaceuticals-rnn-jumps%3A-stock-moves-up-5.4-2017-03-16", "https://www.nasdaq.com/articles/shires-shpg-cinryze-label-expanded-for-pediatric-use-2017-03-16", "https://www.nasdaq.com/articles/endos-endp-opana-ers-risk-benefit-evaluated-by-fda-2017-03-16", "https://www.nasdaq.com/articles/avexis-inc.-avxs-looks-good%3A-stock-moves-15.4-higher-2017-03-20", "https://www.nasdaq.com/articles/health-care-sector-update-03142017-atrsetrmanth-2017-03-14", "https://www.nasdaq.com/articles/vivus-vvus-beats-on-q4-earnings-revenues-increase-y-y-2017-03-09", "https://www.nasdaq.com/articles/new-strong-buy-stocks-march-8th-2017-03-08", "https://www.nasdaq.com/articles/health-care-sector-update-12292016-sny-nvs-gale-anth-nvo-2016-12-29", "https://www.nasdaq.com/articles/anthera-anth-stock-falls-on-poor-phase-iii-sollpura-data-2016-12-28", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-ford-motor-company-f-galena-biopharma-inc-gale-and-anthera", "https://www.nasdaq.com/articles/health-care-sector-update-12282016-sny-anth-jnj-pfe-abt-mrk-amgn-2016-12-28", "https://www.nasdaq.com/articles/health-care-sector-update-03142017-auphetrmanth-2017-03-14", "https://www.nasdaq.com/articles/health-care-sector-update-12282016-snynvsgaleanth-2016-12-28", "https://www.nasdaq.com/articles/health-care-sector-update-12282016-cxrxgaleanth-2016-12-28", "https://www.nasdaq.com/articles/wednesday-sector-laggards-music-electronics-stores-biotechnology-stocks-2016-12-28", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-anthera-pharmaceuticals-anth-stock-2016-12-27", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-anthera-pharmaceuticals-inc-anth-mastercard-inc-ma-and", "https://www.nasdaq.com/articles/health-care-sector-update-12072016-ctsoanthrprx-2016-12-07", "https://www.nasdaq.com/articles/health-care-sector-update-12072016-cgixanthrprx-2016-12-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-biogenionis-drug-seattle-genetics-hit-clinical-hold-2016-12", "https://www.nasdaq.com/articles/health-care-sector-update-11102016-omermnkdanth-2016-11-10", "https://www.nasdaq.com/articles/anthera-pharmaceuticals-anth-jumps%3A-stock-rises-7.9-2016-08-17", "https://www.nasdaq.com/articles/health-care-sector-update-08172016-anthcncincr-2016-08-17", "https://www.nasdaq.com/articles/midday-update-stocks-find-excuse-retreat-record-highs-hawkish-fed-speak-2016-08-16", "https://www.nasdaq.com/articles/close-update-stocks-pressured-hawkish-fed-speak-2016-08-16", "https://www.nasdaq.com/articles/health-care-sector-update-06292016-anthtsrogale-2016-06-29", "https://www.nasdaq.com/articles/can-the-rally-in-anthera-anth-shares-continue-2016-06-03", "https://www.nasdaq.com/articles/wednesday-sector-laggards-precious-metals-biotechnology-stocks-2016-11-30", "https://www.nasdaq.com/articles/health-care-sector-update-03072016-msli-anth-2016-03-07", "https://www.nasdaq.com/articles/after-hours-earnings-report-november-6-2015-anth-hnrg-2015-11-06", "https://www.nasdaq.com/articles/tuesday-sector-laggards-drugs-biotechnology-stocks-2015-10-20", "https://www.nasdaq.com/articles/spark-therapeutics-once-slumps%3A-falls-11.1-in-session-2015-10-08", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-october-6th-2015-10-06", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-september-30th-2015-09-30", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-anthera-anth-2015-09-23", "https://www.nasdaq.com/articles/analysts-anticipate-iwv-hit-133-2016-04-13", "https://www.nasdaq.com/articles/anthera-pharmaceuticals-stock%3A-3-reasons-why-anth-is-a-top-choice-for-momentum-investors", "https://www.nasdaq.com/articles/should-you-sell-anthera-pharmaceuticals-anth-before-earnings-tale-of-the-tape-2015-07-24", "https://www.nasdaq.com/articles/mid-afternoon-market-update-micron-gains-rumor-tsinghua-bid-navient-shares-drop-2015-07-14", "https://www.nasdaq.com/articles/health-care-sector-update-07092015-anthipciaqxp-2015-07-09", "https://www.nasdaq.com/articles/reason-behind-anthera-pharmaceuticals-nasty-tumble-2015-07-09", "https://www.nasdaq.com/articles/forget-biogen-biib-buy-these-3-biotechnology-stocks-instead-stocks-news-2015-07-06", "https://www.nasdaq.com/articles/why-anthera-pharmaceuticals-inc-shares-are-soaring-higher-2015-06-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-medivation-gilead-sciences-regeneron-pharmaceuticals", "https://www.nasdaq.com/articles/will-anthera-pharmaceuticals-anth-continue-to-surge-higher-tale-of-the-tape-2015-05-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-biogen-geron-johnson-johnson-and", "https://www.nasdaq.com/articles/strength-seen-in-anthera-anth%3A-stock-soars-25-tale-of-the-tape-2015-02-11", "https://www.nasdaq.com/articles/health-care-sector-update-02112015-anthhtbxdcth-2015-02-11", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-anthera-pharmaceuticals-anth-tale-of-the-tape-2015-01-07", "https://www.nasdaq.com/articles/qiagens-molecular-diagnostics-global-market-show-strength-analyst-blog-2014-09-26", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-09-25", "https://www.nasdaq.com/articles/health-care-sector-update-06052015-anthptnormp-2015-06-05", "https://www.nasdaq.com/articles/will-anthera-pharmaceuticals-anth-continue-to-surge-higher-tale-of-the-tape-2015-05-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-biogen-geron-johnson-johnson-and", "https://www.nasdaq.com/articles/anthera-acquires-sollpura-from-eli-lilly-analyst-blog-2014-07-18", "https://www.nasdaq.com/articles/exelixis-exel-soars%3A-stock-adds-23-in-session-tale-of-the-tape-2014-07-15", "https://www.nasdaq.com/articles/sector-update-health-care-stocks-swept-biotech-sell-fed-sees-values-stretched-2014-07-15", "https://www.nasdaq.com/articles/sector-update-health-care-2014-07-15-0", "https://www.nasdaq.com/articles/anthera-pharmaceuticals-anth-jumps%3A-stock-rises-10.3-tale-of-the-tape-2014-05-16", "https://www.nasdaq.com/articles/genomic-health-upbeat-on-strong-international-performance-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/biogen-upped-to-outperform-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/data-published-on-alnylams-attr-candidates-analyst-blog-2013-08-29", "https://www.nasdaq.com/articles/voluntary-recall-at-alexion-analyst-blog-2013-08-21", "https://www.nasdaq.com/articles/mannkind-to-raise-%2440m-from-deerfield-analyst-blog-2013-08-19", "https://www.nasdaq.com/articles/pre-market-most-active-mar-12-2012-bac-ing-zoll-yoku-rio-siri-qqq-un-orex-anth-abb-aapl", "https://www.nasdaq.com/articles/zacks-5-rank-additions-for-thursday-tale-of-the-tape-2012-02-23", "https://www.nasdaq.com/articles/wall-street-experts-deutsche-bank-loves-these-stocks-boosted-insider-buying-2012-01-09", "https://www.nasdaq.com/articles/biolinerx-files-for-bl-7010-study-initiation-analyst-blog-2013-09-25"], "Content": []}